0570.HK

China Traditional Chinese Medicine Holdings Co. Ltd. (0570.HK) on Wednesday warned that it expects to report its profit for all of 2024 fell by 90% to 100%, while its adjusted profit also fell by 50% to 60% year-on-year.

The company’s profit totaled 1.4 billion yuan ($191 million) in 2023, according to its latest annual report, meaning last year’s profit will fall to 140 million yuan or even to nil.

The company blamed the big drop on price cuts required by China’s centralized procurement system, as well as intensifying market competition and relatively high costs of medicinal materials. It added that credit, goodwill and plant impairment costs increased during the period. Its profit was also affected by remedial taxes on some of its subsidiaries last year.

Shares of China Traditional Chinese Medicine fell 6.3% to HK$1.92 in Thursday trading after the profit warning’s release.

By Lau Chi HangTo subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Losses continue to widen and debts continue to pile up, Vanke not yet out of the woods

Vanke not out of the woods as losses, debt keep mounting

Despite being taken over by Shenzhen Metro Group and promised full financial support, the developer, while avoiding defaults, reported its loss widened in the first half of 2025 Key Takeaways:…
Mininglamp makes marketing software

Mininglamp IPO advances with key regulatory approval

China’s securities regulator has registered the leading marketing software maker’s Hong Kong listing, which could raise more than $100 million Key Takeaways: Mininglamp’s Hong Kong IPO has been approved by…